Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored (Q35095352)

6 August 2017

1 reference

title

Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored (English)

1 reference

6 August 2017

Jan Buter

1

1 reference

6 August 2017

Herbert M Pinedo

series ordinal

2

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

published in

Current Oncology Reports

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

171-176

1 reference

Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0106-7

The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0106-7

Immunohistological distribution of 5T4 antigen in normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0106-7

Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0106-7

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0106-7

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0106-7

Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0106-7

Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer

21 January 2018

1 reference

12 December 2020

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

12 December 2020

Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer

1 reference

12 December 2020

Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy.

1 reference

12 December 2020

Doxorubicin gradients in human breast cancer.

1 reference

12 December 2020

Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth

1 reference

12 December 2020

Tumor induction of VEGF promoter activity in stromal cells

1 reference

12 December 2020

Natural adjuvants: endogenous activators of dendritic cells

1 reference

12 December 2020

The induction of tolerance by dendritic cells that have captured apoptotic cells

1 reference

12 December 2020

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

12 December 2020

Involvement of platelets in tumour angiogenesis?

1 reference

12 December 2020

Management of locally advanced breast cancer

1 reference

12 December 2020

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

12 December 2020

Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step

1 reference

12 December 2020

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

12 December 2020

Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

1 reference

12 December 2020

Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor

1 reference

12 December 2020

Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications

1 reference

12 December 2020

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

1 reference

12 December 2020

Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma

1 reference

12 December 2020

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

12 December 2020

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

12 December 2020

Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792)

1 reference

12 December 2020

Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis

1 reference

12 December 2020

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

12 December 2020

Treatment of locally advanced breast cancer

1 reference

12 December 2020

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

12 December 2020

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

12 December 2020

Platelet: transporter of vascular endothelial growth factor

1 reference

12 December 2020

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

12 December 2020

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

12 December 2020

Decreased antigen presentation by dendritic cells in patients with breast cancer.

1 reference

12 December 2020

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

12 December 2020

Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerations

1 reference

12 December 2020

Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy

1 reference

12 December 2020

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

1 reference

12 December 2020

Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques

1 reference

12 December 2020

Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience

1 reference

12 December 2020

Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages

1 reference

12 December 2020

Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas

1 reference

12 December 2020

A phase I-II study of intensive-dose adriamycin for advanced breast cancer

1 reference

12 December 2020

Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma

1 reference

12 December 2020

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

12 December 2020

Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets

1 reference

12 December 2020

Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer

1 reference

12 December 2020

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome

1 reference

12 December 2020

Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin

1 reference

12 December 2020

Preclinical studies and clinical correlation of the effect of alkylating dose.

1 reference

12 December 2020

Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells

1 reference

12 December 2020

Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF.

1 reference

12 December 2020

Dendritic cells: a novel therapeutic modality

1 reference

12 December 2020

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

12 December 2020

Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer

1 reference

12 December 2020

Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma

1 reference

12 December 2020

Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer

1 reference

12 December 2020

Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents

1 reference

12 December 2020

Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma

1 reference

12 December 2020

Local Recurrences Following Mastectomy: Support for the Concept of Tumor Dormancy

1 reference

12 December 2020

Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events

1 reference

12 December 2020

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance

1 reference

12 December 2020

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

1 reference

12 December 2020

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

1 reference

12 December 2020

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

12 December 2020

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

1 reference

12 December 2020

Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor

1 reference

12 December 2020

Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers.

1 reference

12 December 2020

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

1 reference

12 December 2020

10.1007/S11912-003-0106-7

Identifiers

DOI

1 reference

6 August 2017

1 reference